Literature DB >> 25613127

Diabetic macular ischaemia is associated with narrower retinal arterioles in patients with type 2 diabetes.

Gerald Liew1, Dawn A Sim, Pearse A Keane, Ava G Tan, Paul Mitchell, Jie Jin Wang, Tien Y Wong, Marcus Fruttiger, Adnan Tufail, Catherine A Egan.   

Abstract

PURPOSE: Diabetic macular ischaemia (DMI) is an important cause of visual loss in patients with diabetes, but its relationship to the larger retinal vessels is unknown. We examined whether retinal vessel calibre is related to DMI.
METHODS: Clinic-based case-control study of patients with type 2 diabetes. The presence and severity of DMI was assessed using Early Treatment Diabetic Retinopathy Study (ETDRS) protocols from fundus fluorescein angiographic (FFA) images. Custom software was used to quantify the greatest linear dimension and area of the foveal avascular zone (FAZ). Retinal vessel calibre was measured using a semi-automated software on fundus fluorescein images.
RESULTS: Of 53 patients examined, 18 (34%), 18 (34%) and 17 (32%) had no/mild, moderate and severe DMI, respectively. Persons with moderate or severe DMI had narrower mean retinal arteriolar calibre than persons with no/mild DMI (140.6 μm 95% confidence interval (CI) 134.7, 146.4 versus 150.7 μm, 95% CI 142.5, 158, p = 0.04). The association remained after multivariate adjustment for age, gender, previous panretinal photocoagulation, neovascularization at the disc and elsewhere and diabetic retinopathy severity. Increased FAZ size was also associated with narrower arteriolar calibre. Retinal venular calibre and arteriole to venule ratio (AVR) were not associated with DMI.
CONCLUSIONS: Retinal arteriolar narrowing was associated with moderate-to-severe macular ischaemia in eyes with diabetic retinopathy. This suggests that larger vessels other than capillaries may also be associated with DMI.
© 2015 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  blood flow; diabetic macular ischaemia; diabetic retinopathy; retinal imaging

Mesh:

Year:  2015        PMID: 25613127     DOI: 10.1111/aos.12519

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  7 in total

1.  Differentiation of arterioles from venules in mouse histology images using machine learning.

Authors:  J Sachi Elkerton; Yiwen Xu; J Geoffrey Pickering; Aaron D Ward
Journal:  J Med Imaging (Bellingham)       Date:  2017-02-28

2.  Sema3A Antibody BI-X Prevents Cell Permeability and Cytoskeletal Collapse in HRMECs and Increases Tip Cell Density in Mouse Oxygen-Induced Retinopathy.

Authors:  Nina Zippel; Cynthia Hess Kenny; Helen Wu; Michel Garneau; Rachel Kroe-Barrett; Priyanka Gupta; Sarah Low; Remko A Bakker; Leo Thomas
Journal:  Transl Vis Sci Technol       Date:  2022-06-01       Impact factor: 3.048

Review 3.  Biomarkers in Diabetic Retinopathy.

Authors:  Alicia J Jenkins; Mugdha V Joglekar; Anandwardhan A Hardikar; Anthony C Keech; David N O'Neal; Andrzej S Januszewski
Journal:  Rev Diabet Stud       Date:  2015-08-10

4.  Retinal microvascular alterations related to diabetes assessed by optical coherence tomography angiography: A cross-sectional analysis.

Authors:  Julien Gozlan; Pierre Ingrand; Olivier Lichtwitz; Agathe Cazet-Supervielle; Léa Benoudis; Michele Boissonnot; Samy Hadjadj; Nicolas Leveziel
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

5.  Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections.

Authors:  Ariana M Levin; Irene Rusu; Anton Orlin; Mrinali P Gupta; Peter Coombs; Donald J D'Amico; Szilárd Kiss
Journal:  Clin Ophthalmol       Date:  2017-01-21

6.  Macular Optical Coherence Tomography Angiography in Nephropathic Patients with Diabetic Retinopathy in Iran: A Prospective Case-Control Study.

Authors:  Ali Ahmadzadeh Amiri; Majid Reza Sheikh Rezaee; Amir Ahmadzadeh Amiri; Tayebeh Soleymanian; Reza Jafari; Ahmad Ahmadzadeh Amiri
Journal:  Ophthalmol Ther       Date:  2020-02-19

7.  HORNBILL: a phase I/IIa trial examining the safety, tolerability and early response of BI 764524 in patients with diabetic retinopathy and diabetic macular ischaemia-rationale, study design and protocol.

Authors:  Victor Chong; Quan Dong Nguyen; Yasir Sepah; Andrea Giani; Elizabeth Pearce
Journal:  Trials       Date:  2022-08-17       Impact factor: 2.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.